Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 17853939)

Published in Acta Med Okayama on August 01, 2007

Authors

Takashi Saika1, Ryoji Arata, Tomoyasu Tsushima, Yasutomo Nasu, Bunzo Suyama, Katsuji Takeda, Shin Ebara, Daisuke Manabe, Tomoko Kobayashi, Ryuta Tanimoto, Hiromi Kumon, Okayama Urological Research Group

Author Affiliations

1: Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. saika@cc.okayama-u.ac.jp

Articles by these authors

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer. Cancer Immunol Immunother (2010) 1.70

Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res (2005) 1.65

Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res (2007) 1.61

Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation (2006) 1.60

Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int (2010) 1.52

Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group. Int J Urol (2010) 1.51

The future of urodynamics: non-invasive ultrasound videourodynamics. Int J Urol (2010) 1.46

High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatments. Acta Med Okayama (2004) 1.42

Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade. J Urol (2008) 1.41

Randomized, controlled trial of secondary prevention of coronary sclerosis in normocholesterolemic patients using pravastatin: final 5-year angiographic follow-up of the Prevention of Coronary Sclerosis (PCS) study. Int J Cardiol (2004) 1.40

Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. BJU Int (2006) 1.36

Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology (2005) 1.35

Description of a 23.9-kilobase chromosomal deletion containing a region encoding fsr genes which mainly determines the gelatinase-negative phenotype of clinical isolates of Enterococcus faecalis in urine. Appl Environ Microbiol (2002) 1.34

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. Cancer Immun (2007) 1.34

Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol (2004) 1.33

Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res (2008) 1.24

Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice. J Virol (2010) 1.22

Bladder Cancer Working Group report. Jpn J Clin Oncol (2010) 1.21

Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol (2004) 1.20

Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem (2009) 1.17

Tuberculous retropharyngeal abscess associated with spinal tuberculosis well controlled by fine-needle aspiration and anti-tuberculous chemotherapy. Intern Med (2010) 1.16

Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma. Urology (2007) 1.14

Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J (2013) 1.12

Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther (2007) 1.12

Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol (2009) 1.09

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum Gene Ther (2003) 1.08

Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa. J Bacteriol (2008) 1.06

Diabetic cystopathy correlates with a long-term decrease in nerve growth factor levels in the bladder and lumbosacral dorsal root Ganglia. J Urol (2002) 1.05

REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med (2007) 1.04

Renal cell carcinoma with a tumor thrombus in the ureter: a case report. BMC Urol (2011) 1.04

Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Med Okayama (2004) 1.04

Dynasore, a dynamin inhibitor, suppresses lamellipodia formation and cancer cell invasion by destabilizing actin filaments. Biochem Biophys Res Commun (2009) 1.03

Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients. Int J Cancer (2007) 1.03

Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res (2011) 1.03

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci (2009) 1.02

Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats. Urology (2005) 1.02

Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development. Int J Oncol (2010) 1.01

Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem (2006) 1.01

Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer. BJU Int (2010) 1.00

Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer. Prostate (2006) 0.99

Phosphatidylinositol 4,5-bisphosphate stimulates vesicle formation from liposomes by brain cytosol. Proc Natl Acad Sci U S A (2002) 0.99

Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. Urology (2010) 0.99

Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. Mol Cancer Res (2009) 0.99

NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer Immun (2003) 0.99

Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection. Int J Urol (2005) 0.99

Vaginoplasty with an M-shaped perineo- scrotal flap in a male-to-female transsexual. Acta Med Okayama (2007) 0.98

Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: interim results of a randomized study in Japanese patients. Jpn J Clin Oncol (2004) 0.98

Kidney function after nephrectomy for renal cell carcinoma. Urology (2004) 0.97

Implication of amphiphysin 1 and dynamin 2 in tubulobulbar complex formation and spermatid release. Cell Struct Funct (2007) 0.97

Robot-assisted laparoscopic radical prostatectomy in the Asian population: modified port configuration and ultradissection. Int J Urol (2010) 0.96

Minimal invasiveness and effectivity of subinguinal microscopic varicocelectomy: a comparative study with retroperitoneal high and laparoscopic approaches. Int J Urol (2005) 0.96

Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model. J Infect Chemother (2007) 0.96

Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice. Pancreas (2002) 0.96

Laparoscopic management of complicated urachal remnants in adults. World J Urol (2012) 0.96

Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol Biotechnol (2014) 0.96

Botulinum toxin type A for the treatment of lower urinary tract disorders. Int J Urol (2012) 0.95

Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Med Oncol (2011) 0.95

A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents (2006) 0.95

Isolation of the pandemic (H1N1) 2009 virus and its reassortant with an H3N2 swine influenza virus from healthy weaning pigs in Thailand in 2011. Virus Res (2012) 0.95

Biofilm formation among methicillin-resistant Staphylococcus aureus isolates from patients with urinary tract infection. Acta Med Okayama (2004) 0.95

Successful retrieval of a broken intravascular ultrasound catheter tip in the coronary artery. J Invasive Cardiol (2010) 0.94

Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation. Eur J Neurosci (2004) 0.94

Long-term consequence of renal function following nephrectomy for renal cell cancer. Int J Urol (2004) 0.93